SmithKline Beecham Paxil
Executive Summary
Scios will co-promote the selective serotonin reuptake inhibitor in the U.S. Janssen also promotes Paxil (paroxetine). Each of the three companies will target specific groups of psychiatrists and physicians to maximize sales. Scios also promotes SmithKline's psychiatric products Thorazine, Stelazine, Parnate, Eskalith and Eskalith CR 450 and Janssen's antipsychotic Risperdal